Pathstone Holdings’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Sell
10,859
-991
-8% -$147K 0.01% 1097
2026
Q1
$1.1M Buy
11,850
+3,542
+43% +$314K ﹤0.01% 1357
2025
Q4
$667K Sell
8,308
-3,301
-28% -$276K ﹤0.01% 1617
2025
Q3
$1.13M Buy
11,609
+3,952
+52% +$318K ﹤0.01% 1345
2025
Q2
$534K Buy
7,657
+497
+7% +$28.4K ﹤0.01% 1694
2025
Q1
$356K Sell
7,160
-936
-12% -$59.2K ﹤0.01% 1875
2024
Q4
$566K Buy
8,096
+13
+0.2% +$1.08K ﹤0.01% 1670
2024
Q3
$848K Buy
8,083
+3,567
+79% +$417K ﹤0.01% 1459
2024
Q2
$642K Sell
4,516
-203
-4% -$23.4K ﹤0.01% 1563
2024
Q1
$526K Sell
4,719
-500
-10% -$59.6K ﹤0.01% 1660
2023
Q4
$677K Buy
+5,219
New +$719K ﹤0.01% 1317

Other funds holding ACLS

Pathstone Holdings's ACLS Position: Q2 2026 in Review

Pathstone Holdings reduced its Axcelis (ACLS) stake by 8.4% in Q2 2026, selling an estimated $147K and leaving 10,859 shares worth $2.06M. The position accounts for 0.01% of the portfolio, ranked #1097.

Pathstone Holdings first reported a position in ACLS in Q4 2023 and has held it in 11 quarters since. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Pathstone Holdings held 10,859 shares of Axcelis worth $2.06M as of Q2 2026.
  • Pathstone Holdings sold 991 Axcelis shares in Q2 2026, an estimated $147K.
  • Axcelis made up 0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1097 holding.
  • Pathstone Holdings first reported a position in Axcelis in Q4 2023 and has held it in 11 quarters since.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.